- OVERVIEW AND WHY SHOULD YOU ATTEND
- AREAS COVERED AND LEARNING OBJECTIVES
- WHO WILL BENEFIT
Different microorganisms in different environments during sterilization have different resistance to the destructive principles that causes the organism or spore to die (lethality). Some extreme thermophile organisms have their optimal growth temperature at 110°C, whereas most vegetative cells are killed at 60°C. Some species (not necessarily spore formers) are highly radiation resistant.
The chemical environment causes significant variance in the death rate of a microorganism. Very dense cell walls, spore coats, or slime layers outside the cell can severely limit the ingress of what is being used to sterilize the product.
General principals used to kill microorganisms such as Steam and Dry Heat which causes denaturization of macromolecules, dissociation of tertiary and secondary structures, and protein agglutination along with destruction of molecular arrangements in the cells caused by radiation. The generation of free radicals causes destruction and re-arrangement of chemical bonds in macromolecules. Chemical disinfection or sterilization causes modifications of macromolecules depending on the agent used.
General Sterilization Terms
D value calculator – all types of sterilization
Z value calcuator – thermal sterilization processes
F-value – thermal sterilization processes that originated from 250oF
FBIO - thermal sterilization for specific organisms
Fo(F sub zero) – moist heat sterilization
FH(F sub H) – dry heat sterilization &depyrogenation
L – Lethality (aka F value) used in various processes
How do we calculate and monitor these different variables in order to generate the required SAL and PNSU based on the bio burden that may be contaminating the product from an API or the process?
why should you attend
Heat sterilization is a PROBABILTY function dependent on heat exposure, the number of microorganisms, and the heat resistance of the microorganisms. Current regulations expect the sterilization process to provide a level of assurance of at least 1 x 10-6probability (fewer than one non-sterile unit per million units) of survival (non-sterility) for terminally sterilized parenterals and medical devices. Since Regulations require that we generate in our sterilization processes a PROBABILITY of a NON-STERILE UNIT (PNSU), how do we use D-values, Z-values and Fo to calculate the probability and determine that we have essentially zero risk in our products due to lack of sterility?
D-value is the term used to describe the amount of time required to kill or destroy a microorganism. Spores are much more difficult to kill than vegetative cells which is why we use spores as our Biological Indicator for the effectiveness monitor of our sterilization process. D121 tells us how many minutes it takes to kill an organism at 121oC (or 250oF) - note the "F". The D-value is the time required to reduce a population of microorganisms by one log at the process temperature. From 1x106 to 1x105 – from 1,000,000 to 100,000 organisms.
Z-value of a microorganism is a measure of how heat resistance changes with changes in temperature. Z is defined as the number of degrees temperature change to change the D-value by a factor of 10. The Z-value allows integration of the lethal effect of heat as the temperature changes during the heating and cooling phases of a sterilization cycle. D121 tells us how many minutes it takes to kill an organism at 121oC (or 250oF) - note the "F"
And then we move on to lethality, the different elements that affect D-value and z-value and how to calculate the probability that a defined cycle is going to give us the SAL and PNSU that is needed to ensure that only or less than 1 in a million patients might have a problem due to sterility issues as well as reviewing what has caused a number of FDA Warning Letter due to inappropriate sterilization development, validation and on-going assessment of the process.Click to View the Pricing Plan
From the topics listed above the areas covered provide the mathematical means of developing and proving the sterilization process is effective and does not generate a problem for heat liable products.
- Survivor Curves to determine D-values and Z-values
- Linear Regression used to calculate the edge of failure
- Fraction Negative studies
- Correction factors associated with heating and cooling
- Cold spot determination - product and chamber - TD and HP
- Calculation of process lethality
- Biological Indicators to be used and how to make the selection
- Laboratory Studies needed to support Sterilizer Studies
- Identification of elements in the process that can affect D-value
FDA wants me to teach this to their field inspectors. Since there is so much different interpretation of regulatory statements and because different agencies have different philosophies, those who do not have a deep comprehension of the sterilization design relative to the microbiological impact (why many sterilizers have been improperly designed), we will discuss the definition of “Sterile” and how to get there by describing different sterilization methods, various approaches to be used for the validation of a sterilization process using moist heat as template that can be used for other sterilization methods and what requirements for routine monitoring and control of sterilization are required.
WHO WILL BENEFIT
- Manufacturing Operations Professionals
- Formulation Professionals
- Engineering Professionals
- QA/QC Professionals
- Product and Process Development Professionals
- Regulatory Affairs Professionals
- Research and Development Professionals
- Sterility Assurance Professionals
- Technical Operations Professionals
- Validation Professionals
Jerry Dalfors has extensive (40+ years) of business administration, consultative, technical and managerial experience in the development and manufacture of highly regulated biopharmaceutical products including injectables, biologics, medical devices and oral dosages. He has held permanent employee, temporary employee and company representative management positions with a multitude of the major pharmaceutical and biotechnology companies in the US.
He has worked with or assisted more than two dozen companies with the establishment of controlled document/quality systems, FDA briefing and submittal documents, project management of several multimillion dollar projects including design, start-up and validation to assure fast track FDA approval by maintaining strict regulatory compliance during all phases of engineering, construction, commissioning and validation, and has written numerous submission documents for product, process and facility approval/licensing which also required the development of quality systems which included customer complaint management, deviation management, CAPA and associated site wide employee training.
Each of his projects have been received and accepted by the FDA and other regulatory agencies. Jerry is considered an expert in most all aspects of the biopharmaceutical and medical device industry and has trained many FDA field inspectors on a variety of topics. None of his work has ever received a 483 but has corrected and prevented many along with Warning Letter remediationView all trainings by this speaker
Moving from an Operational Manager to a Strategic Leader
Speaker: Chris DeVanyTime: 01:00 PM EDT | 10:00 AM PDT
Location: New York
Logistics Channel Incoterms Standards
Speaker: Dr. Rossano V. GeraldTime: 01:00 PM EDT | 10:00 AM PDT
Location: New York
Thank you for the spreadsheet webinar. The webinar was informative and helpful. Although many of the concepts are known and understood by Industrial and Process Engineers, it is always helpful to have a straightforward review. The spreadsheet will be beneficial in being able to help identify areas of risk and areas that may require some attention.
Benchmark Electronics , ******** Engineer
This was a very informative session, it did help my company by raising awareness in areas we lack policies. The only thing I would suggest get added to the session is direct information relating to Accounting, ex. Taxation rules for record retention as they are some records which a company is required to keep indefinitely.
First MCO, ***** Manager
Overall I found the video conference well organized and very informative. The presenter, Ronald Adler, was certainly extremely knowledgeable and presented the subject matter in a well organized, direct and succinct manner. Afford the attendee the ability to track and record paid attendance/activity without a lot of tracking and follow up in order to gather the necessary information required to record the CPEs earned and paid for.
Dynamic Marketing Systems, VP Finance & Human Resources
As this was our first experience, we did not know what to expect. I believe the webinar was informative and to the point, and explained to us the purpose of the I-9, and how the company can be affected by an audit. It really motivated us to review our files and bring them up to date.
Young Transportation, ****Coach****
I have participated in several webinars hosted by Compliance Global on various H&S topics. They are always precise, technologically-oriented, and easy to use and partake in to further my knowledge of current Health and Safety regulations and topics.